Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab

NCT02977052 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma Stage III

Interventions

DRUG: Ipilimumab
DRUG: Nivolumab
PROCEDURE: Surgery
PROCEDURE: Blood for PBMCs
PROCEDURE: Biopsies

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]